GSK plc
GSK
#228
Rank
$103.004 B
Marketcap
United Kingdom
Country
$51.43
Share price
1.04%
Change (1 day)
23.65%
Change (1 year)
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and…
Key Metrics
Trailing P/E
15.81
Forward P/E
10.26
EPS (TTM)
$3.23
Forward EPS
$4.98
Price / Book
4.29
EV / EBITDA
10.8x
Beta
0.29
Dividend Yield
3.61%
Return on Equity
33.38%
Return on Assets
10.01%
Debt / Equity
106.50
Current Ratio
0.81
Gross Margin
73.49%
Operating Margin
30.94%
Net Profit Margin
14.52%
Free Cash Flow
$3.483B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 17
-3.44%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$247.515M
Latest Net Income$43.310M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare GSK plc with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
GSK
No recent news available. Set FINNHUB_API_KEY to enable news.
